Glaxo Rumored to Eliminate 350 Jobs in Philadelphia and Research Triangle Park
The pharma downsizing bandwagon continues to roll. Today, there are unconfirmed reports that GlaxoSmithKline will eliminate about 350 jobs at its R&D facilities in Philadelphia, PA and Research Triangle Park, NC. The area that will be hardiest hit by the cuts is Glaxo’s oncology program, which has not yield much over the past decade or so.
Expect the pharma downsizing trend to continue well into this Fall.
Until next time….
Good Luck and Good Job Hunting (if there are any left to find)!!!!!!
